Detalhe da pesquisa
1.
Higher Levels of SARS-CoV-2 Genetic Variation in Immunocompromised Patients: A Retrospective Case-Control Study.
J Infect Dis
; 229(4): 1041-1049, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37956413
2.
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.
Lancet
; 402(10419): 2295-2306, 2023 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931632
3.
High risk of lung cancer in surfactant-related gene variant carriers.
Eur Respir J
; 63(5)2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575158
4.
Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(1): 104-114, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34919827
5.
Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(9): 1180-1188, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35964621
6.
A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT-0701 MAPS phase 3 trial.
Int J Cancer
; 150(11): 1889-1904, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35262190
7.
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial.
Lancet
; 397(10272): 375-386, 2021 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33485464
8.
Endoscopic follow-up of low-grade precancerous bronchial lesions in high-risk patients: long-term results of the SELEPREBB randomised multicentre trial.
Eur Respir J
; 60(3)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35236723
9.
Apoptosis mapping in space and time of 3D tumor ecosystems reveals transmissibility of cytotoxic cancer death.
PLoS Comput Biol
; 17(3): e1008870, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33784299
10.
The STK38-XPO1 axis, a new actor in physiology and cancer.
Cell Mol Life Sci
; 78(5): 1943-1955, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33145612
11.
The Use of Pro-Angiogenic and/or Pro-Hypoxic miRNAs as Tools to Monitor Patients with Diffuse Gliomas.
Int J Mol Sci
; 23(11)2022 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35682718
12.
Treatment strategies and safety of rechallenge in the setting of immune checkpoint inhibitors-related myositis: a national multicentre study.
Rheumatology (Oxford)
; 60(12): 5753-5764, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33725115
13.
Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology.
Neuroendocrinology
; 111(1-2): 158-169, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32015233
14.
STK38 kinase acts as XPO1 gatekeeper regulating the nuclear export of autophagy proteins and other cargoes.
EMBO Rep
; 20(11): e48150, 2019 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31544310
15.
Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors.
BMC Cancer
; 20(1): 1186, 2020 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33272243
16.
Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial.
Lancet Oncol
; 20(2): 239-253, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30660609
17.
MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial.
Br J Cancer
; 120(4): 387-397, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30739911
18.
Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: a rare case report.
BMC Pulm Med
; 19(1): 12, 2019 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30634951
19.
Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study.
Eur Respir J
; 51(3)2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29545318
20.
A role for RASSF1A in tunneling nanotube formation between cells through GEFH1/Rab11 pathway control.
Cell Commun Signal
; 16(1): 66, 2018 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30305100